SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-14-005669
Filing Date
2014-10-10
Accepted
2014-10-10 10:21:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 d6155118_13-g.htm SC 13G 153091
  Complete submission text file 0000919574-14-005669.txt   154603
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-46083 | Film No.: 141151473
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 237 PARK AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 237 PARK AVENUE, 9TH FLOOR NEW YORK NY 10017 212-808-2463
Broadfin Capital, LLC (Filed by) CIK: 0001511901 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G